Colgate-Palmolive Company $CL Stock Sold by Voya Investment Management LLC

Voya Investment Management LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 33.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 331,908 shares of the company’s stock after selling 165,752 shares during the quarter. Voya Investment Management LLC’s holdings in Colgate-Palmolive were worth $28,318,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. State Street Corp lifted its holdings in shares of Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after purchasing an additional 46,476,510 shares during the period. Bank of New York Mellon Corp grew its position in Colgate-Palmolive by 8.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after buying an additional 1,010,872 shares during the last quarter. First Eagle Investment Management LLC increased its stake in Colgate-Palmolive by 1.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after buying an additional 88,917 shares during the period. Amundi increased its stake in Colgate-Palmolive by 19.9% in the 2nd quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after buying an additional 1,033,918 shares during the period. Finally, Bank of America Corp DE acquired a new position in Colgate-Palmolive in the 2nd quarter valued at $567,483,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.8%

NYSE:CL opened at $98.65 on Friday. Colgate-Palmolive Company has a 1 year low of $75.96 and a 1 year high of $101.81. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. The stock has a fifty day moving average price of $92.04 and a two-hundred day moving average price of $90.53. The stock has a market capitalization of $78.42 billion, a price-to-earnings ratio of 38.69, a PEG ratio of 4.57 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. During the same period in the previous year, the firm earned $0.91 EPS. The business’s revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Tuesday, October 20th were issued a dividend of $0.53 per share. The ex-dividend date of this dividend was Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.1%. Colgate-Palmolive’s payout ratio is currently 83.14%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CL shares. Bank of America upped their price objective on shares of Colgate-Palmolive from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, November 2nd. BNP Paribas Exane reaffirmed an “outperform” rating and issued a $108.00 target price (up from $97.00) on shares of Colgate-Palmolive in a report on Monday, November 2nd. Evercore boosted their price target on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a research note on Thursday, October 8th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, September 21st. Finally, Weiss Ratings cut shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $101.22.

Get Our Latest Analysis on Colgate-Palmolive

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 4,100 shares of the stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $97.97, for a total value of $401,677.00. Following the completion of the transaction, the executive vice president directly owned 10,061 shares of the company’s stock, valued at approximately $985,676.17. This trade represents a 28.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Noel Wallace sold 20,000 shares of the stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the completion of the transaction, the chief executive officer directly owned 359,700 shares of the company’s stock, valued at approximately $36,063,522. This trade represents a 5.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 77,414 shares of company stock valued at $7,613,786. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.